Aquestive Therapeutics
AQST
AQST
56 hedge funds and large institutions have $101M invested in Aquestive Therapeutics in 2019 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 12 increasing their positions, 12 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
56
Holders Change
+21
Holders Change %
+60%
% of All Funds
1.11%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
28
Increased
12
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$4.3M |
2 |
WCM
Wildcat Capital Management
New York
|
+$2.65M |
3 |
EP
Eversept Partners
New York
|
+$2.04M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.82M |
5 |
D.E. Shaw & Co
New York
|
+$1.53M |